Irani Zackary S.'s Form 4 filing
Biomerica Inc (BMRA) · filed May 1, 2023
- Accession no.
- 0001513162-23-000078
- Filed
- May 1, 2023
- Trade date
- Apr 27-28, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $5.82K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Irani Zackary S.CIK 0001282349 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 27, 2023 | Common Stock | PPurchaseAcquired | +2,600 | $1.31 | +$3,406 | 1,017,360 | Direct | |
| Apr 28, 2023 | Common Stock | PPurchaseAcquired | +1,800 | $1.34 | +$2,412 | 1,017,360 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.